Jessica Okosun
banner
jessicaokosun.bsky.social
Jessica Okosun
@jessicaokosun.bsky.social
Professor & Physician Scientist @qmbci.bsky.social. Lymphoma specialist @ Barts Health. Our lab research interests: cancer heterogeneity, somatic evolution, biomarkers, multi-omics, translational lymphoma research
Reposted by Jessica Okosun
I am excited to share our lab's first review out with in Blood Cancer Journal. We discuss the impact of transposable elements on genome regulation and variation in both normal
haematopoietic processes and haematological cancers. www.nature.com/articles/s41...
Transposable elements as genome regulators in normal and malignant haematopoiesis - Blood Cancer Journal
Blood Cancer Journal - Transposable elements as genome regulators in normal and malignant haematopoiesis
www.nature.com
May 6, 2025 at 4:31 PM
Our lab at @qmbci.bsky.social is #hiring! Do you have expertise in molecular biology, bioinformatics & a passion for technology development? WE are looking for a postdoc to take a deep dive into the molecular underpinnings of residual disease in lymphoma. Details 👇
qmul-jobs.tal.net/vx/mobile-0/...
April 17, 2025 at 11:11 PM
Reposted by Jessica Okosun
!THREE OPPORTUNITIES TO JOIN US!

We are looking for 3 (!!!) PhD students interested in:
How Metabolism affects Genome Regulation.

Join us at @carrerasijc.bsky.social as Marie Sklodowska Curie network fellow.

More info:
2 x experimental: www.nuclear-dn.eu
1 x computational: www.hubmol.eu
February 12, 2025 at 3:34 PM
Reposted by Jessica Okosun
Zooming in on how multiple myeloma starts to spread in the body: Single-cell analyses and spatial omics allowed international researchers, including the @simonhaas.bsky.social lab at the #mdcBerlin, to see a co-evolution of blood cancer and immune cells. #ScienceImmunology

More details 👇
When blood cancer starts to spread
When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers from Berlin and Heidelberg report in “Sci...
www.mdc-berlin.de
February 11, 2025 at 5:11 PM
Reposted by Jessica Okosun
Today our study using copy number alterations (CNAs) from low-coverage WGS to predict FUTURE colorectal cancer in patients with IBD is published, details in thread! 1/5
gut.bmj.com/content/earl...
Low-coverage whole genome sequencing of low-grade dysplasia strongly predicts advanced neoplasia risk in ulcerative colitis
Background The risk of developing advanced neoplasia (AN; colorectal cancer and/or high-grade dysplasia) in ulcerative colitis (UC) patients with a low-grade dysplasia (LGD) lesion is variable and dif...
gut.bmj.com
January 30, 2025 at 3:56 PM
Our lab at is #hiring! Open #postdoc position for a mixed dry-wet lab to leverage multi-omic techniques to determine biomarkers of response and resistance B-cell #lymphomas treated with #CAR-T therapy. Deadline 26th February. Reach out if interested or kindly share.
qmul-jobs.tal.net/vx/mobile-0/...
January 29, 2025 at 10:41 PM
Reposted by Jessica Okosun
📰 Some forms of DNA damage linger unrepaired in healthy cells for years, according to a @nature.com study led by Dr Mike Spencer Chapman @mikespencerchapman.bsky.social at BCI and @sangerinstitute.bsky.social

The findings could inform our understanding of #cancer development. 🧪 #medsky
Discovery of lingering DNA damage could change our understanding of cancer development - Barts Cancer Institute - Queen Mary University of London
Dr Michael Spencer Chapman and team have uncovered forms of DNA damage in healthy cells that can persist unrepaired for years.
bit.ly
January 15, 2025 at 4:42 PM